Michael Burry’s Warning for Investors: Hedge Funds and C-suites Weekly (Investing.com)
Here is your weekly roundup of the biggest news out of hedge funds and company top brass, all first covered on InvestingPro+. Aveanna Healthcare Holdings Inc (NASDAQ:AVAH), whose stock has fallen 89% year to date, said it was appointing a new CEO – current COO Jeff Shaner – and that current CEO Tony Strange would retire at the end of the year. Shaner said, “I am looking forward to this new leadership role as CEO and further building on the rock-solid commitment we have to clinical excellence and value creation here at Aveanna.” Shares were up 6.9% for the week.
Bigger Was Better In 2022: Global Hedge-Fund Industry Sees Split (FA-mag.com)
A handful of giant firms are gaining dominance over the hottest corners of the hedge fund industry. This year showed why. While nearly all hedge fund indexes are negative, a closer look at the data shows that multi-strategy and macro funds with the biggest concentration of investors’ cash posted gains, shielding clients from a ferocious selloff in global markets as central banks began raising rates and rolling back years of quantitative easing. Giants from Citadel to Millennium Management produced double-digit gains as their army of traders once again earned steady returns. Those betting on macro economic trends, such as $5 billion Haidar Capital and $15.5 billion Rokos Capital Management, are poised for record annual gains.
Thursday 12/15 Insider Buying Report: PRTS, BHIL (Nasdaq.com)
At CarParts.com, a filing with the SEC revealed that on Wednesday, Director Jim Barnes purchased 24,600 shares of PRTS, for a cost of $6.12 each, for a total investment of $150,552. So far Barnes is in the green, up about 8.8% on their buy based on today’s trading high of $6.66. CarParts.com is trading up about 5.3% on the day Thursday. This purchase marks the first one filed by Barnes in the past twelve months. And on Monday, Chief Financial Officer Dean P. Freeman bought $150,029 worth of Benson Hill, buying 59,230 shares at a cost of $2.53 each. Before this latest buy, Freeman made one other buy in the past year, purchasing $168,500 shares at a cost of $3.37 a piece. Benson Hill is trading down about 2.5% on the day Thursday.
$10 Million Bet On Dyne Therapeutics? Check Out These 4 Stocks Insiders Are Buying (Benzinga)
Dyne Therapeutics: The Trade: Dyne Therapeutics, Inc. (DYN) Director Jason Rhodes acquired a total of 934,581 shares at an average price of $10.70. To acquire these shares, it cost around $10 million. Harrow Health: The Trade: Harrow Health, Inc. (HROW) 10% owner Opaleye Management Inc bought a total 431,183 shares at an average price of $10.52. The insider spent around $4.54 million to buy those shares.
SEC Probes PLDT Shares Selloff for Possible Insider Trading (Inquirer.net)
The Securities and Exchange Commission (SEC) ordered an investigation of possible insider trading related to PLDT Inc.’s disclosure of a P48- billion “budget overrun” covering several years. “The reported ‘budget overruns’, as well as the selloff in PLDT shares before the publicly listed company could make the official disclosure, are areas of concern for the Commission, being the regulator of the securities market and the champion of investor protection in the country,” the corporate regulator said in a statement on Monday.
